scispace - formally typeset
B

Bandaru S. Reddy

Researcher at Rutgers University

Publications -  277
Citations -  28225

Bandaru S. Reddy is an academic researcher from Rutgers University. The author has contributed to research in topics: Azoxymethane & Colorectal cancer. The author has an hindex of 97, co-authored 277 publications receiving 27634 citations. Previous affiliations of Bandaru S. Reddy include Pharmacia & Dana Corporation.

Papers
More filters
Journal Article

Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis.

TL;DR: O-, and p-methoxy-BSC, p-XSC and DDS possess potential chemopreventive properties in colon cancer and the effects of these agents when administered during the initiation or postinitiation periods were investigated.
Journal ArticleDOI

The epidemiology of cancer of the large bowel.

TL;DR: In the rat model, lithocholic acid and deoxycholic acid, which are present in high concentration in the stool of man, acted as tumor promotors to an established large-bowel carcinogen, and it remains to be shown whether this established association is causative in nature.
Journal ArticleDOI

Wheat Bran Oil and Its Fractions Inhibit Human Colon Cancer Cell Growth and Intestinal Tumorigenesis in Apcmin/+ Mice

TL;DR: The results showed that the oil fraction of WB was more active than the water fraction against the growth of human colon cancer cell lines and that 2% WB oil significantly inhibited the overall tumorigenesis by 35.7% in the Apc(min/+) mouse model.
Journal ArticleDOI

Fecal constituents of a high-risk North American and a low-risk Finnish population for the development of large bowel cancer.

TL;DR: The data suggest that the greater fecal bulk in Kuopio may dilute tumorigenic compounds which come in direct contact with the colon mucosa.
Journal ArticleDOI

Environmental dietary factors in colorectal cancer. Some unresolved issues.

TL;DR: This work has shown clear improvements in the prognosis for large bowel cancer in women with a history of prior treatment with chemotherapy or radiation, particularly on the basis of once-weekly check-up and once-a-year follow-up for women without cancer.